WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Related articles：
Related suggestion：
Ohio man fatally shot Uber driver after scammers targeted both of them, authorities sayFirefighting variant of AG600 seaplane ready for type certificationITV are quietly shelving a popular spinAsian CL semifinal postponed in United Arab Emirates after flooding caused by heavy rainGirls Aloud poke fun at iconic clip where Cheryl insisted they would NEVER get back togetherVan Thinh Phat case tests investor confidence in Vietnam — Radio Free AsiaAsian CL semifinal postponed in United Arab Emirates after flooding caused by heavy rainJosie Gibson's dating history: From falling for her Big Brother coZheng eases past Cîrstea in Stuttgart opener after long trip from China. Paolini also throughOlivia Williams opens up on 'harrowing' experience as guest star on season four finale of Friends
2.6634s , 6500.2734375 kb
Copyright © 2024 Powered by 5 takeaways from the abortion pill case before the U.S. Supreme Court ,Stellar Scope news portal